Premium
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Cesca Therapeutics Inc is clinical-stage biotechnology company. The company is engaged in developing and manufacturing automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. The company's device division, Therm... Cesca Therapeutics Inc is clinical-stage biotechnology company. The company is engaged in developing and manufacturing automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. The company's device division, ThermoGenesis Corp, provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. Cesca's clinical development division is leveraging its proprietary AutoXpress technology platform to develop autologous stem cell-based therapies that address significant unmet needs in the immuno-oncology, vascular, cardiology and orthopedic markets. Show more
Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic Focus ThermoGenesis to Focus on Developing Automated Cell Processing Tools and Services for the Cell and Gene Therapy...
Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference PR Newswire RANCHO CORDOVA, Calif., Oct. 24, 2019 RANCHO CORDOVA, Calif., Oct. 24, 2019...
Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Services ImmuneCyte to Begin Operations in Fourth Quarter of 2019 PR...
Cesca Therapeutics To Present At The 2019 Bio Investor Forum PR Newswire RANCHO CORDOVA, Calif., Oct. 14, 2019 RANCHO CORDOVA, Calif., Oct. 14, 2019 /PRNewswire/ -- Cesca Therapeutics Inc...
Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution Fee PR Newswire RANCHO CORDOVA, Calif., Oct. 2, 2019 RANCHO CORDOVA, Calif., Oct. 2, 2019 /PRNewswire/ -- Cesca...
ThermoGenesis Reports Performance Evaluations of X-Series® Cell Processing Devices PR Newswire RANCHO CORDOVA, Calif., Sept. 25, 2019 RANCHO CORDOVA, Calif., Sept. 25, 2019 /PRNewswire/ -- Cesca...
Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® Products PR Newswire RANCHO CORDOVA, Calif., Sept. 9, 2019 RANCHO CORDOVA, Calif...
Cesca Therapeutics To Present At The H.C. Wainwright 21st Annual Global Investment Conference PR Newswire RANCHO CORDOVA, Calif., Sept. 3, 2019 RANCHO CORDOVA, Calif., Sept. 3, 2019 /PRNewswire/...
Cesca Therapeutics Announces Improved Second Quarter 2019 Financial Results and Provides Corporate Update Revenue Grows by 115% and the Company Records Positive Adjusted EBITDA for the Second...
Cesca Therapeutics To Announce Financial Results For The Second Quarter Ended June 30, 2019 And Host A Conference Call On August 13 PR Newswire RANCHO CORDOVA, Calif., Aug. 6, 2019 RANCHO...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
